UnitedHealth Group Incorporated (NYSE:UNH) Stock Position Lessened by JB Capital LLC

JB Capital LLC decreased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH) by 83.2% during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 1,197 shares of the healthcare conglomerate’s stock after selling 5,946 shares during the period. JB Capital LLC’s holdings in UnitedHealth Group were worth $606,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also made changes to their positions in the company. Princeton Global Asset Management LLC lifted its holdings in shares of UnitedHealth Group by 0.8% in the fourth quarter. Princeton Global Asset Management LLC now owns 23,351 shares of the healthcare conglomerate’s stock valued at $11,812,000 after buying an additional 183 shares during the period. Oregon Pacific Wealth Management LLC bought a new position in shares of UnitedHealth Group during the 4th quarter valued at about $424,000. Means Investment CO. Inc. raised its holdings in shares of UnitedHealth Group by 5.7% in the 4th quarter. Means Investment CO. Inc. now owns 4,862 shares of the healthcare conglomerate’s stock worth $2,459,000 after purchasing an additional 262 shares in the last quarter. Abner Herrman & Brock LLC grew its position in UnitedHealth Group by 3.1% in the fourth quarter. Abner Herrman & Brock LLC now owns 24,412 shares of the healthcare conglomerate’s stock worth $12,349,000 after buying an additional 737 shares during the last quarter. Finally, Magnolia Capital Advisors LLC boosted its stake in shares of UnitedHealth Group by 110.2% during the 4th quarter. Magnolia Capital Advisors LLC now owns 3,806 shares of the healthcare conglomerate’s stock worth $1,925,000 after acquiring an additional 1,995 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors.

Wall Street Analysts Forecast Growth

Several equities research analysts have recently commented on UNH shares. UBS Group reduced their target price on UnitedHealth Group from $680.00 to $650.00 and set a “buy” rating for the company in a report on Wednesday, October 16th. HSBC raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $595.00 target price on the stock in a research report on Friday, January 10th. StockNews.com upgraded shares of UnitedHealth Group from a “hold” rating to a “buy” rating in a research report on Thursday, January 23rd. Deutsche Bank Aktiengesellschaft raised their target price on UnitedHealth Group from $595.00 to $625.00 and gave the stock a “buy” rating in a research report on Tuesday, December 3rd. Finally, Stephens raised their price objective on UnitedHealth Group from $605.00 to $675.00 and gave the stock an “overweight” rating in a research report on Thursday, December 5th. One equities research analyst has rated the stock with a hold rating, twenty have issued a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock currently has an average rating of “Buy” and an average price target of $629.32.

Insider Buying and Selling

In other UnitedHealth Group news, Director Timothy Patrick Flynn purchased 1,000 shares of the stock in a transaction on Friday, January 17th. The shares were purchased at an average price of $511.57 per share, with a total value of $511,570.00. Following the acquisition, the director now directly owns 4,500 shares of the company’s stock, valued at $2,302,065. This represents a 28.57 % increase in their position. The transaction was disclosed in a filing with the SEC, which is accessible through this link. 0.33% of the stock is owned by company insiders.

UnitedHealth Group Price Performance

Shares of UnitedHealth Group stock opened at $542.30 on Monday. The stock has a market capitalization of $499.07 billion, a price-to-earnings ratio of 34.99, a PEG ratio of 1.48 and a beta of 0.61. UnitedHealth Group Incorporated has a 1-year low of $436.38 and a 1-year high of $630.73. The company has a current ratio of 0.83, a quick ratio of 0.91 and a debt-to-equity ratio of 0.74. The firm has a fifty day simple moving average of $536.17 and a 200-day simple moving average of $565.26.

UnitedHealth Group (NYSE:UNH) last posted its quarterly earnings data on Thursday, January 16th. The healthcare conglomerate reported $6.81 EPS for the quarter, topping analysts’ consensus estimates of $6.74 by $0.07. UnitedHealth Group had a return on equity of 26.69% and a net margin of 3.60%. The business had revenue of $100.81 billion for the quarter, compared to analyst estimates of $101.60 billion. During the same period in the previous year, the company posted $5.83 earnings per share. The firm’s revenue for the quarter was up 6.8% on a year-over-year basis. On average, sell-side analysts expect that UnitedHealth Group Incorporated will post 29.63 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, December 17th. Stockholders of record on Monday, December 9th were issued a dividend of $2.10 per share. The ex-dividend date was Monday, December 9th. This represents a $8.40 annualized dividend and a dividend yield of 1.55%. UnitedHealth Group’s payout ratio is 54.19%.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.